Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Cramer's Lightning Round: 'I'd be careful' with Novo Nordisk

January 07, 2025

Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown

December 24, 2024

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions

December 24, 2024

CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?

December 22, 2024

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

December 20, 2024

Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results

December 20, 2024

Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal

December 18, 2024

Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch

December 18, 2024

Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition

December 17, 2024

Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing

December 11, 2024

Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly

December 11, 2024

The weight-loss drug boom has become one of the internet's biggest scams

December 08, 2024

Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data

December 05, 2024

Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says

December 05, 2024

Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds

December 04, 2024

Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial

December 04, 2024

5 things to know before the stock market opens Tuesday

November 26, 2024

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

November 26, 2024

Amgen stock falls as analysts mull over weight loss drug’s bone density data

November 12, 2024

Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca

November 08, 2024

Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity

October 31, 2024

Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says

October 30, 2024

Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says

October 24, 2024

Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'

October 23, 2024

Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use

October 23, 2024

Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies

October 23, 2024

Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034

October 15, 2024

Cramer's Lightning Round: Uranium Energy is 'the real deal'

October 14, 2024

Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says

October 11, 2024

Ozempic underworld: Inside the black market of obesity drugs

October 09, 2024

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.